Trial intelligence / Profile preview

Remimazolam for Sedation in Elderly Patients Undergoing Lower Limb Surgery

NCT05468996Phase 4Completed

Sponsor
Asan Medical Center
Start
May 2022
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam, sponsored by Asan Medical Center. Started May 2022; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT05468996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05468996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call